journal article·2020-04

Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem/progenitor cells

Huilei Yu, Jin Cheng, Weili Shi, Bo Ren, Fengyuan Zhao, Yuanyuan Shi, Peng Yang, Xiaoning Duan, Jiying Zhang, Xin Fu, Xiaoqing Hu, Yingfang Ao

Acta Biomaterialia· Volume 106
Publisher page

Abstract

Mesenchymal stem cells (MSCs)-derived exosomes are being increasingly focused as the new biological pro-regenerative therapeutic agents for various types of tissue injury. Here, we explored the potential of a novel exosome-based therapeutic application combined with a local fibrin delivery strategy for tendon repair. After discovering that bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exos) promoted the proliferation, migration and tenogenic differentiation of tendon stem/progenitor cells (TSPCs) in vitro, we embedded BMSCs-exos in fibrin and injected it into the defect area of rat patellar tendon, and the results showed that the exosomes could be controlled-released from the fibrin, retained within the defect area, and internalized by TSPCs. BMSCs-exos embedded in fibrin significantly improved the histological scores, enhanced the expression of mohawk, tenomodulin, and type I collagen, as well as the mechanical properties of neotendon, and also promoted the proliferation of local TSPCs in vivo. Overall, we demonstrated the beneficial role of BMSCs-exos in tendon regeneration, and that fibrin-exosomes delivery system represents a successful local treatment strategy of exosomes. This study brings prospects in the potential application of exosomes in novel therapies for tendon injury. STATEMENT OF SIGNIFICANCE: Mesenchymal stem cells have been identified as a preferred approach in tissue regeneration. In this study, we reported bone marrow mesenchymal stem cells (BMSCs) promote the proliferation and migration of tendon stem/progenitor cells (TSPCs) via the paracrine signaling effect of the nanoscale exosomes. We also demonstrated that the application of BMSCs-derived exosomes might be a promising approach to activate the regenerative potential of endogenous TSPCs in tendon injured region, and fibrin-exosomes delivery system represents a successful local treatment strategy of exosomes.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tendon Structure and Treatment · Sports injuries and prevention · Musculoskeletal synovial abnormalities and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Progress in cell-based therapies for tendon repair10.1016/j.addr.2014.11.023 ↗
2. The past, present and future in scaffold-based tendon treatments10.1016/j.addr.2014.11.022 ↗
3. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model10.1111/j.1440-1797.2012.01589.x ↗
4. Renal regenerative potential of different extracellular vesicle populations derived from bone marrow mesenchymal stromal cells10.1089/ten.tea.2017.0069 ↗
5. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine10.1186/s13287-018-0791-7 ↗
6. Concise review: MSC-derived exosomes for cell-free therapy10.1002/stem.2575 ↗
7. Tenocyte proliferation and migration promoted by rat bone marrow mesenchymal stem cell-derived conditioned medium10.1007/s10529-017-2446-7 ↗
8. Mesenchymal stem cell secretome improves tendon cell viability in vitro and tendon-bone healing in vivo when a tissue engineering strategy is used in a rat model of chronic massive rotator cuff tear10.1177/0363546517735850 ↗
9. Stepwise differentiation of mesenchymal stem cells augments tendon-like tissue formation and defect repair in vivo10.5966/sctm.2015-0215 ↗
10. Mesenchymal stem cells for tendon healing: what is on the horizon?10.1002/term.2209 ↗
11. The use of cocultured mesenchymal stem cells with tendon-derived stem cells as a better cell source for tendon repair10.1089/ten.tea.2016.0248 ↗
12. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice10.3402/jev.v4.26238 ↗
13. Tendon-derived stem cells (TDSCs) promote tendon repair in a rat patellar tendon window defect model10.1002/jor.21559 ↗
14. Fibrin glue mesh fixation combined with mesenchymal stem cells or exosomes modulates the inflammatory reaction in a murine model of incisional hernia10.1016/j.actbio.2018.02.014 ↗
15. Polycaprolactone electrospun mesh conjugated with an msc affinity peptide for msc homing in vivo10.1016/j.biomaterials.2012.01.033 ↗
16. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche10.1038/nm1630 ↗
17. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity10.1016/j.cell.2017.08.035 ↗
18. Human adipose-derived stem cell conditioned media and exosomes containing MALAT1 promote human dermal fibroblast migration and ischemic wound healing10.1089/wound.2017.0775 ↗
19. Enhanced therapeutic effects of MSC-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment10.1021/acsami.8b08449 ↗
20. Histone deacetylase inhibitor treated cell sheet from mouse tendon stem/progenitor cells promotes tendon repair10.1016/j.biomaterials.2018.03.043 ↗
21. Well-aligned chitosan-based ultrafine fibers committed teno-lineage differentiation of human induced pluripotent stem cells for achilles tendon regeneration10.1016/j.biomaterials.2015.02.051 ↗
22. Harnessing endogenous stem/progenitor cells for tendon regeneration10.1172/JCI81589 ↗
23. Biologics for tendon repair10.1016/j.addr.2014.11.015 ↗
24. Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit achilles tendon model10.2106/JBJS.E.01396 ↗
25. Mesenchymal stem cells from a hypoxic culture improve and engraft achilles tendon repair10.1177/0363546513480786 ↗
26. Mesenchymal stem cells in tendon repair and regeneration: basic understanding and translational challenges10.1111/nyas.13262 ↗
27. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs10.1038/nature23282 ↗
28. Exosomal small talk carries strong messages from muscle stem cells10.1016/j.stem.2016.12.009 ↗
29. Macrophage-derived miRNA-containing exosomes induce peritendinous fibrosis after tendon injury through the miR-21-5p/Smad7 pathway10.1016/j.omtn.2018.11.006 ↗
30. Extracellular vesicle-educated macrophages promote early achilles tendon healing10.1002/stem.2988 ↗
31. Tenocyte-derived exosomes induce the tenogenic differentiation of mesenchymal stem cells through TGF-β10.1007/s10616-018-0264-y ↗
32. Stem cell-derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair10.1002/jor.24406 ↗
33. Extracellular vesicles from bone marrow-derived multipotent mesenchymal stromal cells regulate inflammation and enhance tendon healing10.1186/s12967-019-1960-x ↗
34. Comparison of tenocytes and mesenchymal stem cells seeded on biodegradable scaffolds in a full-size tendon defect model10.1007/s10856-012-4791-3 ↗
35. Loss of tenomodulin results in reduced self-renewal and augmented senescence of tendon stem/progenitor cells10.1089/scd.2014.0314 ↗
36. Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing10.1038/cddis.2017.510 ↗
37. Expression of tenocyte lineage-related factors in regenerated tissue at sites of tendon defect10.1007/s00776-014-0684-2 ↗
38. The regulation of tendon stem cell differentiation by the alignment of nanofibers10.1016/j.biomaterials.2009.11.083 ↗
39. Engineered scaffold-free tendon tissue produced by tendon-derived stem cells10.1016/j.biomaterials.2012.11.046 ↗
40. Cells and secretome–towards endogenous cell re-activation for cartilage repair10.1016/j.addr.2014.08.007 ↗
41. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy10.1002/cbin.10378 ↗
42. PEDF-derived peptide promotes tendon regeneration through its mitogenic effect on tendon stem/progenitor cells10.1186/s13287-018-1110-z ↗
43. In vivo identity of tendon stem cells and the roles of stem cells in tendon healing10.1089/scd.2013.0073 ↗
44. Re-engineering extracellular vesicles as smart nanoscale therapeutics10.1021/acsnano.6b07607 ↗
45. Engineered exosomes as vehicles for biologically active proteins10.1016/j.ymthe.2017.03.030 ↗
46. Functional delivery of lipid-conjugated siRNA by extracellular vesicles10.1016/j.ymthe.2017.03.021 ↗
47. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy10.1016/j.biomaterials.2017.10.012 ↗
48. Resident c-kit(+) cells in the heart are not cardiac stem cells10.1038/ncomms9701 ↗
49. Reassessment of c-Kit(+) cells for cardiomyocyte contribution in adult heart10.1161/CIRCULATIONAHA.119.039909 ↗
50. Chitosan wound dressings incorporating exosomes derived from microrna-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model10.5966/sctm.2016-0275 ↗
51. Thermoresponsive gel embedding adipose stem cell-derived extracellular vesicles promotes esophageal fistula healing in a thermo-actuated delivery strategy10.1021/acsnano.8b00117 ↗
52. Fibrin glue as a drug delivery system10.1016/j.jconrel.2010.06.025 ↗